Funded Startups in Park City
Across 18 Park City–listed funding records (from 2020-02-18 to 2026-06-24), the largest disclosed round is NuView Life Sciences’ $90M (2020-08-03), which d…
Across 18 Park City–listed funding records (from 2020-02-18 to 2026-06-24), the largest disclosed round is NuView Life Sciences’ $90M (2020-08-03), which dwarfs every other disclosed amount in the table; the next-largest disclosed figures are $60M (Nexus IT Consultants, 2025-06-09) and $50K (4C Design Group, 2026-01-22), with most other disclosed rounds clustered between $1M and $5M. The disclosed data also shows a stage-and-sector mix skew: “Series Unknown” appears in 10 of 18 rows, while “undisclosed” shows up in 6 of 18, limiting disclosed-size comparisons for more than half the entries. Temporal concentration is visible in 2024–2025, where multiple records arrive in tight spans (for example, 2024-06-04 to 2024-06-05 includes Split Second Research and MRP), and the newest entries are concentrated in mid-2026 (Pale Blue on 2026-06-24 and Bene on 2026-06-01). Sector-wise, Biotechnology appears 3 times (Control Medical Technology in 2024-08-20, Domus Diagnostics in 2023-05-24, and NuView Life Sciences in 2020-08-03), alongside frequent crossovers across software, AI, and health-related categories.
Most recent rounds
18 shownRelated listings
Frequently asked
What stands out in disclosed round sizes, and does any single deal control the range?
NuView Life Sciences’ $90M (2020-08-03) is the only disclosed round that sits far above the rest, with Nexus IT Consultants at $60M (2025-06-09) and CIRCA Scientific at $4M (2024-09-20) trailing considerably. Below that top tier, disclosed amounts frequently land between $1M and $5M, while 4C Design Group’s $50K (2026-01-22) is the smallest disclosed amount.
How much of the Park City list lacks disclosed funding size or a defined round label?
Funding size is undisclosed in 6 of 18 rows (for example, Pale Blue on 2026-06-24 and Bene on 2026-06-01), and “Series Unknown” is present in 10 of 18 rows (including Pale Blue, SubcontractorHub on 2026-03-02, and Ouma Health on 2024-10-09). The combination means disclosed comparisons by size are limited to the 12 rows that provide dollar amounts.
Are there visible date clusters among the most recent entries?
Yes. The newest window runs through mid-2026, including Bene (2026-06-01) and Pale Blue (2026-06-24). A separate 2024 cluster appears around 2024-06-04 to 2024-06-05, when Split Second Research (2024-06-04, undisclosed) and MRP (2024-06-05, undisclosed) both surface within one day.
Which stages and sectors dominate, based on what’s actually labeled in the table?
Stage labeling is heavily incomplete: “Series Unknown” accounts for 10 of 18 rows, while only 3 rows show a named stage with a disclosed amount (for example, Treads Seed $5M on 2023-11-02, Oka Seed $3M on 2025-07-01, and Oka’s $3M is paired with clearly labeled Seed stage). On the sector side, Biotechnology appears 3 times (Control Medical Technology 2024-08-20 at $1M, Domus Diagnostics 2023-05-24 at $2M, and NuView Life Sciences 2020-08-03 at $90M).
Are there outliers that merit sector-specific or company-specific follow-up?
NuView Life Sciences is a clear size outlier at $90M (2020-08-03) within Biotechnology. On the low end, 4C Design Group’s $50K (2026-01-22) is the smallest disclosed amount and sits alongside multiple multi-million disclosures such as Feasibly’s $1M (2025-11-30) and Oka’s $3M (2025-07-01).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.